Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element

Endocrinology

Volumn 138, Issue 7, 1997, Pages 2900-2908

  Uht, Rosalie M ^a   Anderson, Carol M ^b   Webb, Paul ^c   Kushner, Peter J ^a,d  

^a Metabolic Research Unit   (United States)

^b Department of Pathology ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ESTROGEN; ESTROGEN RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; TAMOXIFEN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HYPOTHALAMUS; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

EID: 0030910876     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.7.5244     Document Type: Article

References (53)

1. Bigsby RM 1993 Progesterone and dexamethasone inhibition of estrogeninduced synthesis of DNA and complement in rat uterine epithelium: effects of antiprogesterone compounds. J Steroid Biochem Mol Biol 45:295-301
2. Burgess LH, Handa RJ 1992 Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology 131:1261-1269
3. Morse JK, DeKosky ST, Scheff SW1992 Neurotrophic effects of steroids on lesion-induced growth in the hippocampus. Exp Neurol 118:47-52
4. Toran-Allerand CD 1996 Mechanisms of estrogen action during neural development: mediation by interactions with the neurotrophins and their receptors? J Steroid Biochem Mol Biol 56:169-178
5. Sapolsky RM, Uno H, Rebert CS, Finch CE 1990 Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 10:2897-2902
6. Oursler MJ, Pederson L, Fitzpatrick L, Riggs BL, Speisberg T 1994 Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc NatI Acad Sci USA 91:5227-5231
7. Jilka RL, Hangoc G, Girasole G, Passen G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
8. Shwto T, Kukita T, Hirala M, Jimi E, Koga T1994 Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures. Endocrinology 134:1121-1126
9. Zhou F, Bouillard B, Pharaboz-Joly MO, Andre J 1989 Non-classical antiestrogenic actions of dexamethasone in variant MCF-7 human breast cancer cells in culture. Mol Cell Endocrinol 66:189-197
10. Prodi G, De Giovanni C, Galli MC, Gola G, Grilli S, Rocchetta R, Orlandi C 1979 ITbeta-estradiol, Salpha-dihydrotestosterone, progesterone and cortisol receptors in normal and neoplastic human endometrium. Tumori 65:241-253
11. Fuxe K, Wikstrom A-C, Okret S, Agnati L, Harfslrand A, Yu Z-Y, Granholm L, Zoli M, Vale W, Gustafsson J-A 1985 Mapping of glucocorticoid receptor immunorcactivc neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 117: 1803-1812
12. Simerly KB, Chang C, Muramatsu M, Swanson LW 1990 Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in silu hybridization study. J Comp Neurol 294:76-95
13. Liesegang P, Romalo G, Sudmann M, Wolf L, Schweikert H-U1994 Human osteoblast-like cells contain specific, saturable, high-affinity glucocorticoid, androgen, estrogen, and 1 alpha,25-dihydroxycholecalciferol receptors. J Androl 15:194-199
14. Wong GL 1979 Basal activities and hormone responsiveness of osteoclast-like and osteoblast-like bone cells are regulated by glucocorticoids. J Biol Chem 254:6337-6340
15. Ewing TM, Murphy LJ, Ng M-L, Pang GYN, Lee CSL, Watts CKW, Sutherland RL 1989 Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines. Int J Cancer 44:744-752
16. Mader S, Kumar V, de Verneuil H, Chambon P19S9 Three amino acids of the oestrogen receptor are essential to its ability to distinguish an estrogen from a glucocorticoid-responsive element. Nature 338:271-274
17. Klock G, Strahle U, Schutz G 1987 Oestrogen and glucocorticoid responsive elements are closely related but distinct. Nature 329:734-736
18. Gaub M-P, Bellard M, Scheuer I, Chambon P, Sassone-Corsi P 1990 Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell 63:1267-1276
19. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
20. Ponta H, Cato ACB, Herrlich P 1992 Interference of pathway specific transcription factors. Biochim Biophys Acta 1129:255-261
21. Mellon P, Windle JJ, Goldsmith PC, Padula CA, Roberts JL, Weiner RI1990 Immortalization of hypothalamic GnRH neurons by genetically targeted tu- ' morigenesis. Neuron 5:1-10
22. Lopez G, Schaufele F, Webb P, Holloway, Baxter JD, Kushner PJ 1993 Positive and negative modulation of jun action by thyroid hormone receptor at a unique API site. Mol Cell Biol 13:3042-3049
23. Starr DB, Matsui WR, TJ, Yamamoto KR 1996 Intracellular receptors use a common mechanism to interpret signaling information at response elements. Genes Dev 10:1271-1283
24. Green S, Waller P, Kumar V, Krust A, Bornert J-M, Argos P, Chambon P1986 Human oestrogen receptor cDMA: sequence, expression and homology to v-erb-A. Nature 320:134-139
25. Tora L, Mullick A, Metzger D, Fonglikitmongkol M, Park I, Chambon P19S9 The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8:1981-1956
26. Kumar V, Green S, Staub A, Chambon P 19S6 Localisation of the oestradiolbinding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 5:2231-2236
27. Kumar V, Green S, Stack G, Berry M, Jin J-R, Chambon F 19S7 Functional domains of the human estrogen receptor. Cell 51:941-931
28. McEwan IJ, Wright APH, Dahlman-Wright K, Carlstedt-Duke J, Gustafsson J-A 1993 Direct interaction of the tau-1 transactivation domain of the human glucocorticoid receptor with the basal transcriptional machinery. Mol Cell Biol 13:399-407
29. Law M, Kao F, Wei Q, Hartz J, Greene G, Zarucki-Schulz T, Conneely O, Jones C, Puck T, O'Malley B, Horwitz K1987 The progesterone receptor gene maps to human chromosome band Ilql3 site of the mammary oncogens int-2. Proc Natl Acad Sci USA 84:2877-2881
30. Wei L, Krett N, Francis M, Gordon D, Wood W, O'Malley B, Honvitz K1988 Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells. Mol Endocrinol 2:62-72
31. Kushner PJ, Hort E, Shine J, Baxter JD, Greene GL1990 Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol Endocrinol 4:1465-1473
32. Turner R, Tjian R1989 Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cjun heterodimers. Science 243:1689-1694
33. Cohen DR, Ferreira PCP, Gentz R, Franza Jr BR 1989 The product of a fos-related gene, fra-l, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes Dev 3:173-184
34. Doucas V, Spyrou G, Yaniv M 1991 Unregulated expression of c-Jun or c-Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cells. EMBO J 10:2237-2245
35. Teurich S, Angel P 1995 The glucocorticoid receptor synergizes with jun homodimers to activate AP-1-regulated promoters lacking GR binding sites. Chem Senses 20:251-255
36. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR 1990 Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272
37. Boyle WJ, Smeal T, Defize LH, Angel P, Woodgelt JR, Karin M, Hunter T 1991 Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64:373-584
38. Westwick JK, Weitzel C, Minden A, Karin M, Brenner DA 1994 Tumor necrosis factor-alpha stimulates AP-1 activity through prolonged activation of the c-jun kinase. J Biol Chem 269:26396-26401 .
39. Chandran UR, Attardi B, Friedman R, Dong K-W, Roberts JL, DeFranco DB 1994 Glucocorticoid receptor-mediated repression of gonadotropin-releasing hormone promoter activity in GT1 hypothalamic cell lines. Endocrinology 134:1467-1474
40. Bamberger A-M, Bamberger CH, Gellersen B, Schulte HM 1996 Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proc Natl Acad Sci USA 93:6169-6174
41. Meyer ME, Gronemeyer H, Turcotte B, Bocquel MT, Tassel D, Chambon P 19S9 Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57:433-442
42. Sahlin I. 1995 Dexamethasone attenuates the cstradiol-induced increase of 1GF-1 mRNA in the rat uterus. J Steroid Biochem Mol Biol 55:9-15
43. Brot MD, De Vries GJ, Dorsa DM 1993 Local implants of testosterone metabolites regulate vasopressin mRNA in sexually dimorphic nuclei of the rat brain. Peptides 14:933-940
44. Albeck DS, Hastings NB, McEwen BS1994 Effects of adrenalectomy and Type I or Type II glucocorticoid receptor activation on AVP and CRH mRNA in the rat hypothalamus. Mol Brain Res 26:129-134
45. Wilcox JN, Roberts JL 1985 Estrogen decreases rat hypothalamic proopiomelanocortin messenger ribonucleic acid levels. Endocrinology 117: 2329-2396
46. Poletti A, Melcangi RC, Negri-Cesi P, Maggi R, Martini L 1994 Steroid binding and metabolism in the luteinizing hormone-releasing hormone-producing neuronal cell line GT1-1. Endocrinology 135:2623-2628
47. Bruder JM, Krebs WD, Nett TM, Wierman ME 1992 Phorbol ester activation of the protein kinase C pathway inhibits gonadotropin-releasing hormone gene expression. Endocrinology 131:2552-2558
48. Schule R, Umesono K, Mangelsdorf DJ, Bolado J, Pike JW, Evans RM 1990 Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 61:497-504
49. Ozono K, Liao J, Kerner S A, Scott RA, Pike JW 1990 The vitamin D-responsive element in the human osteocalcin gene; association with a nuclear protooncogene enhancer. J Biol Chem 265:21831-21888
50. Schule R, Rangarajan P, Yang N, Kliewer S, Ransone LJ, Bolado J, Verma IM, Evans RM 1991 Retinoic acid is a negative regulator of AP-1-rcsponsive genes. Proc Natl Acad Sci USA 88:6092-6096
51. Kallio PJ, Poukka H, Moilanen A, Janne OA, Falvimo JJ 1995 Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol Endocrinol 9:1017-1028
52. Arias J, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M, Feramisco J, Montminy M 1994 Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370:226-229
53. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG 1996 A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414